Jerry L. Bauman

3.0k total citations
108 papers, 2.1k citations indexed

About

Jerry L. Bauman is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Jerry L. Bauman has authored 108 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Cardiology and Cardiovascular Medicine, 17 papers in Molecular Biology and 16 papers in Geriatrics and Gerontology. Recurrent topics in Jerry L. Bauman's work include Cardiac electrophysiology and arrhythmias (54 papers), Cardiac Arrhythmias and Treatments (26 papers) and Pharmaceutical Practices and Patient Outcomes (16 papers). Jerry L. Bauman is often cited by papers focused on Cardiac electrophysiology and arrhythmias (54 papers), Cardiac Arrhythmias and Treatments (26 papers) and Pharmaceutical Practices and Patient Outcomes (16 papers). Jerry L. Bauman collaborates with scholars based in United States, Netherlands and New Zealand. Jerry L. Bauman's co-authors include Robert J. Hariman, Robert J. DiDomenico, Cynthia A. Sanoski, Karen J. Beckman, Jose Gallastegui, Bhakti Arondekar, Glen T. Schumock, Melissa G. Butler, Lee C. Vermeulen and Patrick D. Meek and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Jerry L. Bauman

104 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerry L. Bauman United States 24 1.1k 390 366 211 209 108 2.1k
Torben Haghfelt Denmark 28 2.2k 1.9× 186 0.5× 467 1.3× 359 1.7× 266 1.3× 115 4.4k
Odd Brørs Norway 21 210 0.2× 279 0.7× 278 0.8× 184 0.9× 216 1.0× 64 1.4k
Susanna M. Wallerstedt Sweden 28 360 0.3× 149 0.4× 524 1.4× 80 0.4× 257 1.2× 128 3.1k
Philip A. Routledge United Kingdom 26 325 0.3× 329 0.8× 465 1.3× 198 0.9× 431 2.1× 91 2.8k
Claes Mörlin Sweden 12 1.7k 1.5× 128 0.3× 616 1.7× 70 0.3× 132 0.6× 37 2.6k
Gillian M. Shenfield Australia 28 279 0.2× 200 0.5× 258 0.7× 84 0.4× 322 1.5× 114 2.3k
Pieter A. de Graeff Netherlands 24 1.3k 1.1× 213 0.5× 125 0.3× 53 0.3× 140 0.7× 63 2.1k
E. M. Hawes Canada 24 643 0.6× 390 1.0× 158 0.4× 52 0.2× 132 0.6× 143 2.1k
Peter H. Vlasses United States 28 741 0.6× 486 1.2× 250 0.7× 94 0.4× 307 1.5× 176 2.9k
Hilary Wynne United Kingdom 28 690 0.6× 236 0.6× 366 1.0× 189 0.9× 361 1.7× 76 3.5k

Countries citing papers authored by Jerry L. Bauman

Since Specialization
Citations

This map shows the geographic impact of Jerry L. Bauman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry L. Bauman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry L. Bauman more than expected).

Fields of papers citing papers by Jerry L. Bauman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry L. Bauman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry L. Bauman. The network helps show where Jerry L. Bauman may publish in the future.

Co-authorship network of co-authors of Jerry L. Bauman

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry L. Bauman. A scholar is included among the top collaborators of Jerry L. Bauman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry L. Bauman. Jerry L. Bauman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Alexandre, William L. Baker, Daniel Abazia, et al.. (2025). Impact of artificial intelligence on future clinical pharmacy research and scholarship. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(4). 311–316. 2 indexed citations
2.
Adams, Kirkwood F., Jalal K. Ghali, J. Herbert Patterson, et al.. (2014). A Perspective on Re-Evaluating Digoxin's Role in the Current Management of Patients with Chronic Systolic Heart Failure: Targeting Serum Concentration to Reduce Hospitalization and Improve Safety Profile. European Journal of Heart Failure. 16(5). 483–493. 18 indexed citations
3.
Bauman, Jerry L.. (2006). A Method of Determining the Dose of Digoxin for Heart Failure in the Modern Era. Archives of Internal Medicine. 166(22). 2539–2539. 27 indexed citations
4.
Bauman, Jerry L. & Robert J. DiDomenico. (2002). Cocaine-Induced Channelopathies: Emerging Evidence on the Multiple Mechanisms of Sudden Death. Journal of Cardiovascular Pharmacology and Therapeutics. 7(3). 195–202. 45 indexed citations
5.
DiDomenico, Robert J., et al.. (2001). Impact of the Cost of Prescription Drugs on Clinical Outcomes in Indigent Patients with Heart Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(12). 1455–1463. 52 indexed citations
6.
Southworth, Mary, et al.. (1999). Comparison of sotalol versus quinidine for maintenance of normal sinus rhythm in patients with chronic atrial fibrillation. The American Journal of Cardiology. 83(12). 1629–1632. 25 indexed citations
7.
Sanoski, Cynthia A., et al.. (1998). Rationale, Development, and Clinical Outcomes of a Multidisciplinary Amiodarone Clinic. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(6P2). 146S–151S. 17 indexed citations
8.
Bauman, Jerry L.. (1997). Class III Antiarrhythmic Agents: The Next Wave. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(2P2). 76S–83S; discussion 89S. 7 indexed citations
9.
Phillips, Bradley G., et al.. (1997). Comparison of Intravenous Diltiazem and Verapamil for the Acute Treatment of Atrial Fibrillation and Atrial Flutter. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(6). 1238–1245. 38 indexed citations
10.
Phillips, Bradley G., et al.. (1996). Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals. American Heart Journal. 131(5). 872–878. 16 indexed citations
11.
Hariman, Robert J., et al.. (1994). Reversal of the Electrocardiographic Effects of Cocaine by Lidocaine. Part 2. Concentration‐Effect Relationships. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 14(6). 704–711. 17 indexed citations
12.
Hariman, Robert J., et al.. (1994). Reversal of the Electrocardiographic Effects of Cocaine by Lidocaine. Part 1. Comparison With Sodium Bicarbonate and Quinidine. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 14(6). 698–703. 30 indexed citations
13.
O’Toole, Michael F., et al.. (1994). “Late” proarrhythmia due to quinidine. The American Journal of Cardiology. 74(2). 192–194. 14 indexed citations
14.
McCollam, Patrick L., et al.. (1992). Impact of food on the pharmacokinetics and electrocardiographic effects of sustained release verapamil in normal subjects. The American Journal of Cardiology. 70(11). 1072–1076. 12 indexed citations
15.
Bauman, Jerry L., et al.. (1992). Follow-up Observations on 24-Hour Pharmacotherapy Services in the Emergency Department. Annals of Pharmacotherapy. 26(4). 476–480. 13 indexed citations
16.
Schrader, Bruce J., et al.. (1991). Evaluation of drug therapy for treatment of hypertensive urgencies in the emergency department. The American Journal of Emergency Medicine. 9(2). 107–111. 13 indexed citations
17.
Beckman, Karen J., Jose Gallastegui, Jerry L. Bauman, & Robert J. Hariman. (1990). The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome. Journal of the American College of Cardiology. 15(3). 640–647. 42 indexed citations
18.
McCollam, Patrick L., Jerry L. Bauman, Karen J. Beckman, & Robert J. Hariman. (1989). A simple method of monitoring antiarrhythmic drugs during short- and long-term therapy. The American Journal of Cardiology. 63(17). 1273–1275. 5 indexed citations
19.
Gallastegui, Jose, Jerry L. Bauman, Jeffrey L. Anderson, et al.. (1988). Worsening of Ventricular Tachycardia by Amiodarone. The Journal of Clinical Pharmacology. 28(5). 406–411. 3 indexed citations
20.
Shanes, Jeffrey G., et al.. (1988). Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy: Relevance of intrinsic sympathomimetic activity. American Heart Journal. 116(5). 1268–1275. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Torben Haghfelt Breakdown of academic impact, for papers by Odd Brørs Breakdown of academic impact, for papers by Susanna M. Wallerstedt Breakdown of academic impact, for papers by Philip A. Routledge Breakdown of academic impact, for papers by Claes Mörlin Breakdown of academic impact, for papers by Gillian M. Shenfield Breakdown of academic impact, for papers by Pieter A. de Graeff Breakdown of academic impact, for papers by E. M. Hawes Breakdown of academic impact, for papers by Peter H. Vlasses Breakdown of academic impact, for papers by Hilary Wynne
Rankless by CCL
2026